tiprankstipranks
Trending News
More News >
Ars Pharmaceuticals, Inc. (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Ratios

Compare
564 Followers

ARS Pharmaceuticals Ratios

SPRY's free cash flow for Q4 2025 was $0.89. For the 2025 fiscal year, SPRY's free cash flow was decreased by $ and operating cash flow was $-1.48. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
7.28 7.28 14.26 96.85 51.01
Quick Ratio
7.06 7.06 14.04 96.85 51.01
Cash Ratio
1.06 1.06 2.17 29.68 38.67
Solvency Ratio
-0.79 -0.80 0.09 -22.36 -4.02
Operating Cash Flow Ratio
-4.36 -4.36 0.58 -24.79 -7.36
Short-Term Operating Cash Flow Coverage
-290.59 -290.59 0.00 -250.07 0.00
Net Current Asset Value
$ 71.50M$ 71.50M$ 239.94M$ 229.13M$ 269.15M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.30 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.85 0.85 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.46 0.46 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.46 0.46 0.00 0.00 0.00
Financial Leverage Ratio
2.87 2.87 1.37 1.01 1.03
Debt Service Coverage Ratio
85.17 -55.85 0.00 -284.59 0.00
Interest Coverage Ratio
69.05 -69.05 0.00 0.00 0.00
Debt to Market Cap
0.11 0.08 0.00 <0.01 0.00
Interest Debt Per Share
0.96 1.01 <0.01 <0.01 0.01
Net Debt to EBITDA
-0.32 -0.31 16.90 1.05 5.97
Profitability Margins
Gross Profit Margin
75.77%75.77%76.94%100.00%100.00%
EBIT Margin
-207.26%-212.92%-3.46%-225066.67%-2698.78%
EBITDA Margin
-203.31%-211.30%-3.37%-224823.33%-2674.54%
Operating Profit Margin
-212.92%-212.92%-3.46%-225066.67%-2698.78%
Pretax Profit Margin
-203.35%-203.35%9.29%-181216.67%-2635.41%
Net Profit Margin
-203.25%-203.25%8.97%-181216.67%-2635.41%
Continuous Operations Profit Margin
-203.25%-203.25%8.97%-181216.67%-2635.41%
Net Income Per EBT
99.95%99.95%96.52%100.00%100.00%
EBT Per EBIT
95.50%95.50%-268.76%80.52%97.65%
Return on Assets (ROA)
-52.28%-52.28%2.28%-23.31%-12.32%
Return on Equity (ROE)
-100.29%-149.92%3.11%-23.56%-12.71%
Return on Capital Employed (ROCE)
-62.20%-62.20%-0.94%-29.26%-12.87%
Return on Invested Capital (ROIC)
-62.04%-62.04%-0.91%-29.23%-12.86%
Return on Tangible Assets
-54.69%-54.69%2.33%-23.31%-12.32%
Earnings Yield
-19.98%-14.92%0.78%-10.42%-10.18%
Efficiency Ratios
Receivables Turnover
3.32 3.32 9.73 0.04 0.00
Payables Turnover
3.57 3.57 2.08 0.00 0.00
Inventory Turnover
2.44 2.44 3.94 0.00 0.00
Fixed Asset Turnover
34.19 34.19 83.63 0.04 1.70
Asset Turnover
0.26 0.26 0.25 <0.01 <0.01
Working Capital Turnover Ratio
0.32 0.30 0.33 <0.01 <0.01
Cash Conversion Cycle
157.03 157.03 -45.19 9.67K 0.00
Days of Sales Outstanding
109.78 109.78 37.51 9.67K 0.00
Days of Inventory Outstanding
149.57 149.57 92.54 0.00 0.00
Days of Payables Outstanding
102.32 102.32 175.25 0.00 0.00
Operating Cycle
259.35 259.35 130.05 9.67K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.73 -1.73 0.14 -0.62 -1.00
Free Cash Flow Per Share
-1.74 -1.74 0.13 -0.62 -1.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 0.96 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-504.03 -504.03 24.06 -338.66 -201.40
Capital Expenditure Coverage Ratio
-504.03 -504.03 24.06 -338.66 -201.40
Operating Cash Flow Coverage Ratio
-1.76 -1.76 322.57 -216.30 -83.32
Operating Cash Flow to Sales Ratio
-2.03 -2.03 0.15 -1.98K -30.45
Free Cash Flow Yield
-19.91%-14.91%1.27%-11.39%-11.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.01 -6.70 127.87 -9.60 -9.83
Price-to-Sales (P/S) Ratio
10.20 13.63 11.47 17.39K 258.99
Price-to-Book (P/B) Ratio
7.51 10.05 3.98 2.26 1.25
Price-to-Free Cash Flow (P/FCF) Ratio
-5.02 -6.71 78.76 -8.78 -8.46
Price-to-Operating Cash Flow Ratio
-5.02 -6.72 75.49 -8.80 -8.50
Price-to-Earnings Growth (PEG) Ratio
0.04 <0.01 -1.12 0.28 -0.40
Price-to-Fair Value
7.51 10.05 3.98 2.26 1.25
Enterprise Value Multiple
-5.34 -6.76 -323.54 -6.69 -3.72
Enterprise Value
915.63M 1.20B 971.91M 451.08M 130.79M
EV to EBITDA
-5.34 -6.76 -323.54 -6.69 -3.72
EV to Sales
10.86 14.29 10.90 15.04K 99.38
EV to Free Cash Flow
-5.35 -7.03 74.85 -7.59 -3.25
EV to Operating Cash Flow
-5.36 -7.05 71.74 -7.61 -3.26
Tangible Book Value Per Share
1.01 1.01 2.57 2.42 6.83
Shareholders’ Equity Per Share
1.16 1.16 2.65 2.42 6.83
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 0.03 0.00 0.00
Revenue Per Share
0.86 0.86 0.92 <0.01 0.03
Net Income Per Share
-1.74 -1.74 0.08 -0.57 -0.87
Tax Burden
1.00 1.00 0.97 1.00 1.00
Interest Burden
0.98 0.96 -2.69 0.81 0.98
Research & Development to Revenue
0.16 0.16 0.22 675.53 13.96
SG&A to Revenue
0.64 0.00 0.00 1.58K 14.02
Stock-Based Compensation to Revenue
0.26 0.26 0.16 307.83 4.44
Income Quality
1.00 1.00 1.69 1.09 1.16
Currency in USD